Results 71 to 80 of about 9,755 (171)

High N-glycan multiplicity is critical for neuronal adhesion and sensitizes the developing cerebellum to N-glycosylation defect

open access: yeseLife, 2018
Proper brain development relies highly on protein N-glycosylation to sustain neuronal migration, axon guidance and synaptic physiology. Impairing the N-glycosylation pathway at early steps produces broad neurological symptoms identified in congenital ...
Daniel Medina-Cano   +12 more
doaj   +1 more source

ALG12‐CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant

open access: yesMolecular Genetics & Genomic Medicine, 2020
Background Congenital disorder of glycosylation (CDG) type I is a group of rare disorders caused by recessive mutations in up to 25 genes that impair the N‐glycan precursor formation and its transfer to proteins resulting in hypoglycosylation of multiple
María Eugenia de laMorena‐Barrio   +10 more
doaj   +1 more source

The efficacy of high pressure liquid chromatography (HPLC) in detecting congenital glycosylation disorders (CDG)

open access: yesTürk Biyokimya Dergisi
Congenital disorders of glycosylation (CDG) are a family of rare inherited metabolic disorders. This study aimed to examine the carbohydrate-deficient transferrin (CDT) screening results of 1,328 patients with suspected CDG by using transferrin-high ...
Ozgen Ozge   +9 more
doaj   +1 more source

Modeling Congenital Disorders of N-Linked Glycoprotein Glycosylation in Drosophila melanogaster

open access: yesFrontiers in Genetics, 2018
Protein glycosylation, the enzymatic addition of N-linked or O-linked glycans to proteins, serves crucial functions in animal cells and requires the action of glycosyltransferases, glycosidases and nucleotide-sugar transporters, localized in the ...
Anna Frappaolo   +6 more
doaj   +1 more source

Normal transferrin glycosylation does not rule out severe ALG1 deficiency

open access: yesJIMD Reports
ALG1‐CDG is a rare, clinically variable metabolic disease, caused by the defect of adding the first mannose (Man) to N‐acetylglucosamine (GlcNAc2)‐pyrophosphate (PP)‐dolichol to the growing oligosaccharide chain, resulting in impaired N‐glycosylation of ...
Inez Bosnyak   +4 more
doaj   +1 more source

Plasma glycoproteomics delivers high-specificity disease biomarkers by detecting site-specific glycosylation abnormalities

open access: yesJournal of Advanced Research
Introduction: The human plasma glycoproteome holds enormous potential to identify personalized biomarkers for diagnostics. Glycoproteomics has matured into a technology for plasma N-glycoproteome analysis but further evolution towards clinical ...
Hans J.C.T. Wessels   +12 more
doaj   +1 more source

From hepatosplenomegaly to genetic diagnosis: A case of congenital disorder of glycosylation type IIb due to mannosyl-oligosaccharide glucosidase mutation

open access: yesJournal of Integrative Medicine and Research
Congenital disorders of glycosylation (CDG) are rare metabolic conditions with heterogeneous presentations, often complicating diagnosis. We report a 5-year-old male born to consanguineous parents, presenting with a 2-year history of painless abdominal ...
Hari Nandan Reddy Golla   +4 more
doaj   +1 more source

Congenital disorders of glycosylation (CDG): state of the art in 2022. [PDF]

open access: yesOrphanet J Rare Dis, 2023
Francisco R   +6 more
europepmc   +1 more source

Hemostatic defects in congenital disorders of glycosylation. [PDF]

open access: yesRes Pract Thromb Haemost, 2023
Pascreau T, Auditeau C, Borgel D.
europepmc   +1 more source

Home - About - Disclaimer - Privacy